Exercise May Be More Effective Than Chemotherapy in Extending Life for Colorectal Cancer Patients
For individuals facing a colorectal cancer diagnosis, the addition of regular physical activity to their treatment plan may offer a significant boost to their chances of long-term survival, potentially even exceeding the benefits of chemotherapy alone. Groundbreaking research published in the prestigious New England Journal of Medicine has revealed that patients who consistently engage in exercise following treatment demonstrate an impressive 7.1% higher eight-year overall survival rate compared to those who do not. This finding positions exercise as a potentially pivotal component of cancer care, offering a powerful and accessible tool in the fight against this disease.
The question of whether exercise truly benefits cancer patients has long been debated within the medical community and among those directly affected by the disease. While the intuitive benefits of physical activity are widely acknowledged, concrete, high-level scientific evidence supporting its impact on cancer outcomes has been limited – until now. Previous studies often relied on animal models or observational data, providing encouraging signals but lacking the definitive proof needed to change clinical practice. Still, a landmark study completed in June 2025 has fundamentally altered this landscape.
The CHALLENGE Trial: A New Standard of Evidence
The research, known as the CHALLENGE trial, was conducted by the Canadian Cancer Clinical Trials Group (CCTG) and published in the New England Journal of Medicine. This study is particularly significant as it represents the first report with Level 1 evidence – the highest standard in medical research – demonstrating a clear link between regular exercise and improved outcomes for colorectal cancer patients. The trial’s design and results are poised to revolutionize how we approach cancer treatment and survivorship.
The CHALLENGE trial focused on patients who had already completed surgery and chemotherapy for stage II high-risk or stage III colon cancer. Participants were randomly divided into two groups: one group received standard post-treatment care, including health education materials, while the other group participated in a structured, three-year exercise program. This program incorporated moderate-intensity aerobic exercise, such as brisk walking, and was supervised by trained professionals who provided behavioral support to encourage adherence. The study followed participants for nearly eight years, yielding remarkable results.
According to Dr. Anxin Yu, a family medicine specialist at Chiayi Christian Hospital, the study’s design was crucial. “The strength of the CHALLENGE trial lies in its rigorous methodology,” she explained. “The randomized controlled trial design minimizes bias and allows us to confidently attribute the observed benefits to the exercise intervention.”
Significant Improvements in Survival Rates
The results of the CHALLENGE trial were striking. The exercise group exhibited a five-year disease-free survival rate of 80.3%, a significant improvement compared to the 73.9% rate observed in the control group. More importantly, the eight-year overall survival rate was substantially higher in the exercise group. This translates to a meaningful extension of life for patients who prioritize physical activity after cancer treatment.
These findings align with a separate, groundbreaking international study published in June 2025 and presented at the American Society of Clinical Oncology (ASCO) annual meeting. This research, detailed in the same issue of the New England Journal of Medicine, also demonstrated that a three-year exercise program significantly improved survival rates and reduced disease recurrence in colorectal cancer patients. Experts are hailing this research as “extremely exciting,” marking the first time a randomized controlled trial has definitively linked exercise to reduced cancer recurrence and improved survival.
What Kind of Exercise is Most Beneficial?
While the CHALLENGE trial specifically focused on moderate-intensity aerobic exercise like brisk walking, the broader implications suggest that a variety of physical activities can be beneficial. The key is consistency and finding activities that patients enjoy and can sustain over the long term. It’s important to note that patients should consult with their healthcare team before starting any new exercise program, particularly after cancer treatment, to ensure it is safe and appropriate for their individual needs and health status.
The benefits of exercise extend beyond simply improving survival rates. Physical activity can also help manage treatment-related side effects, such as fatigue, pain, and anxiety. It can also improve quality of life, boost mood, and enhance overall physical function. These benefits contribute to a more holistic approach to cancer care, addressing not only the disease itself but also the well-being of the patient.
Implications for Cancer Care and Future Research
The findings from the CHALLENGE trial and the concurrent international study have significant implications for how we approach colorectal cancer care. Experts are now advocating for the integration of exercise guidance into the standard of care for colorectal cancer survivors. This could involve incorporating exercise programs into cancer centers and advocating for insurance coverage of supervised exercise interventions.
“Given the benefits comparable to some medications, cancer centers and insurance plans should consider incorporating exercise guidance into the standard care for colorectal cancer survivors,” stated experts commenting on the ASCO presentation. This shift in perspective underscores the growing recognition of exercise as a powerful and cost-effective tool in the fight against cancer.
Further research is needed to explore the optimal type, intensity, and duration of exercise for different cancer types and patient populations. Investigating the underlying mechanisms by which exercise impacts cancer outcomes is also crucial. However, the current evidence is compelling enough to encourage healthcare professionals to actively promote exercise as an integral part of cancer prevention and treatment.
The message is clear: for individuals battling or recovering from colorectal cancer, incorporating regular physical activity into their lives is not just a good idea – it may be a life-saving one. The evidence suggests that movement can be as powerful a medicine as any pharmaceutical intervention.
The next step in translating these findings into widespread clinical practice will be the development of accessible and affordable exercise programs tailored to the needs of cancer survivors. Ongoing research will continue to refine our understanding of the optimal exercise prescriptions for different cancer types and stages. Patients are encouraged to discuss their exercise options with their healthcare providers to develop a personalized plan that supports their recovery and well-being.
Do you have experience with exercise during or after cancer treatment? Share your story in the comments below.